Biomimetics and Biomimicry in Engineering

Assisting mums-to-be in water and house births

In Info on 2014/06/12 at 7:05 pm

The medical device we designed to help midwives monitor labour with minimum interruption has seen the light! Different newspapers and media have been attracted to our invention, a team effort from our colleagues in Univ of Edinburgh and NHS, Heriot-Watt University, and us in Loughborough.

This has been a great enterprising opportunity for us. Being able to form a team with engineers, designers, medics and business developers has been truly rewarding. We all showed great enthusiasm and reached out to understand each others’ ‘language’ so we could bring the project to a fruitful completion. Working with midwives for the development of a new medical device was great because they were able to provide us with insightful input during the design stages, and with useful feedback in the development phase.  We hope the device will help the midwives carry out their work in more comfortable conditions, and for future mothers-to-be to benefit from this device that allows them to experience a more dignifying labour.

The work has been presented at the Perinatal Medicine 2014 (Harrogate International Centre, Monday 9th – Wednesday 11th June 2014).

The press releases can be found here and here

More press material can be found here and here and here.

Engineered metal implants to target cancer cells and eradicate side effects of chemotheraphy

In Publications on 2014/03/06 at 12:12 am

The work done by my colleague Dr Asier Unciti-Broceta and our ‘dream team’ has been published in Nature Communications.

Asier proudly presents to the world the work done using his clever “bioorthogonal” method for activating a prodrug by palladium catalyzed dealkylation. What motivates us is to move towards the eradication of the side effects of chemotheraphy (e.g. depleted immune system, hair loss, tiredness, etc) in the very near future. This is done by focusing the cancer treatment only to the affected area. Like a ‘trojan horse’, in our vision we implant the engineered catalyst carrier first. Then, by a selective activation via oral drugs, we produce the chemo-destructive effect with maximum effect on the targeted area, and minimal negative effects (i.e. death) on healthy tissue.

The technology in a 'nutshell'

The technology in a ‘nutshell’

The full paper can be found here.

The press release by University of Edinburgh can be viewed here.

Asier is an academic fellow at the Edinburgh Cancer Research UK Centre at the MRC Institute of Genetics and Molecular Medicine, the University of Edinburgh.

CDT in Embedded Intelligence at Loughborough University

In Funding, Info on 2014/01/09 at 1:07 pm

Loughborough University has been awarded the EPSRC Centre for Doctoral Training (CDT) in Embedded Intelligence. In collaboration with 23 external partners (large companies, SMEs and other organisations that support training and industry impact) and Heriot-Watt as academic partner, this centre will train the engineers and scientists of the future at post-graduate level before they join industry as high calibre employees.

The research activities in this CDT are around the integration of ‘intelligence’ into products, machines, buildings, factories, work environments, transport systems, and supply chains. And nature can inspire the best examples of Embedded Intelligence.

The 4-year programme includes: (i) technical training in key areas of Embedded Intelligence; (ii) non-technical training in the ‘Double Transition’, to equip our students with the skills to be effective researchers during their PhD (from undergraduate into postgrad studies), and to become suitably qualified employees (from students to graduates); and (iii) industry interaction from early days throughout in a myriad of applied research rich-impact activities.

For more information, click here and here.

For the job ad, click here

Follow

Get every new post delivered to your Inbox.